Share Tweet Share Email
Tag: Sagent Pharmeceuticals Inc.
Jeffrey Yordon
Jeffrey Yordon’s company, Sagent Pharmaceuticals, was No. 1 on Crain’s 2013 Fast Fifty list of Chicago’s fastest growing companies and No. 3 in North America on Deloitte’s 2012 Technology Fast 500 list. With more than 40 years of experience in injectable pharmaceuticals, the Northern Illinois University alumnus was the original founding member of four pharmaceutical...
NIU alum Jeff Yordon (center) at NASDAQ. Photo from www.nasdaq.com.
NIU alum Jeff Yordon, CEO of Sagent Pharmaceuticals, Inc. (SGNT) and benefactor of NIU’s Jeffrey and Kimberly Yordon Center, rang the closing bell Monday, June 6, at NASDAQ MarketSite in New York City’s Times Square. Sagent Pharmaceuticals, Inc., which Yordon founded in 2006, is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with...